Wang-Da Liu

1.1k total citations
49 papers, 452 citations indexed

About

Wang-Da Liu is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Wang-Da Liu has authored 49 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 19 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Wang-Da Liu's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (10 papers) and Hepatitis C virus research (9 papers). Wang-Da Liu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (10 papers) and Hepatitis C virus research (9 papers). Wang-Da Liu collaborates with scholars based in Taiwan, China and United States. Wang-Da Liu's co-authors include Wang‐Huei Sheng, Liqun Zhao, Li Zhang, J F Fraumeni, Yu‐Shan Huang, Robert Kneller, W. J. Blot, Gang Xu, Chien‐Ching Hung and Wei‐Cheng You and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Infectious Diseases and Applied Microbiology and Biotechnology.

In The Last Decade

Wang-Da Liu

41 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang-Da Liu Taiwan 13 172 144 118 104 48 49 452
Zeinab Mohseni Afshar Iran 15 212 1.2× 68 0.5× 106 0.9× 26 0.3× 37 0.8× 58 509
Wouter Haazen United States 14 234 1.4× 49 0.3× 242 2.1× 61 0.6× 65 1.4× 28 660
Carolyn Brandt United States 11 250 1.5× 60 0.4× 307 2.6× 85 0.8× 117 2.4× 17 579
A. Frésard France 15 283 1.6× 181 1.3× 243 2.1× 18 0.2× 125 2.6× 47 665
Serena Vita Italy 15 211 1.2× 66 0.5× 333 2.8× 14 0.1× 133 2.8× 49 670
Laura Barcán Argentina 13 102 0.6× 127 0.9× 236 2.0× 36 0.3× 15 0.3× 37 438
J.‐L. Meynard France 13 248 1.4× 39 0.3× 273 2.3× 27 0.3× 44 0.9× 29 485
Rhonda E Colombo United States 10 261 1.5× 43 0.3× 381 3.2× 30 0.3× 25 0.5× 44 535
R. J. A. Diepersloot Netherlands 13 138 0.8× 114 0.8× 296 2.5× 41 0.4× 13 0.3× 16 591

Countries citing papers authored by Wang-Da Liu

Since Specialization
Citations

This map shows the geographic impact of Wang-Da Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang-Da Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang-Da Liu more than expected).

Fields of papers citing papers by Wang-Da Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang-Da Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang-Da Liu. The network helps show where Wang-Da Liu may publish in the future.

Co-authorship network of co-authors of Wang-Da Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wang-Da Liu. A scholar is included among the top collaborators of Wang-Da Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang-Da Liu. Wang-Da Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Chin-Shiang, Hsin‐Yun Sun, Wen-Chi Huang, et al.. (2025). Chlamydia trachomatis infection among at-risk populations in Taiwan: Emergence of genovariant L2b and treatment response to antimicrobials. Journal of Microbiology Immunology and Infection. 58(3). 356–362.
2.
3.
Liu, Wang-Da, Chien‐Yu Cheng, Hsin‐Yun Sun, et al.. (2025). Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related services. Journal of the Formosan Medical Association. 124(11). 1084–1087.
4.
Cheng, Chien‐Yu, Chun-Yuan Lee, Wang-Da Liu, et al.. (2025). Disproportionate presentation of Mpox among people with HIV: A multicenter retrospective cohort study in Taiwan. Journal of Microbiology Immunology and Infection. 58(6). 663–669.
5.
Su, Tung‐Hung, Jiawei Li, Wang-Da Liu, et al.. (2024). Telemedicine facilitates medical care for hospitalized patients in quarantine. Journal of the Formosan Medical Association. 125(1). 83–89.
6.
Chen, Pao‐Yu, et al.. (2024). Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. 79(5). 1196–1200. 1 indexed citations
7.
Ma, Weili, Wang-Da Liu, Hsin‐Yun Sun, et al.. (2024). Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan. Journal of Microbiology Immunology and Infection. 57(3). 426–436. 2 indexed citations
8.
Chen, Kai‐Hsiang, et al.. (2024). Clinical manifestations and viral kinetics of people with Mpox: A case series during the 2023 outbreak in Taiwan. Journal of Microbiology Immunology and Infection. 57(6). 961–965. 2 indexed citations
9.
Wu, Pei‐Ying, Hsin‐Yun Sun, Yu‐Shan Huang, et al.. (2024). Under-utilization of statins among people with HIV who were aged 40 years or older. Journal of Microbiology Immunology and Infection. 57(1). 200–203. 6 indexed citations
10.
Liang, Ching‐Ping, Tai‐Ling Chao, Wang-Da Liu, et al.. (2024). Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis. Applied Microbiology and Biotechnology. 108(1). 522–522. 3 indexed citations
11.
12.
Chen, Kai‐Hsiang, Hsin‐Yun Sun, Yu‐Chung Chuang, et al.. (2023). Higher Serologic Responses of Early Syphilis to Single-dose Benzathine Penicillin G Plus Doxycycline Versus Single-dose Benzathine Penicillin G Alone Among People With HIV. Clinical Infectious Diseases. 79(5). 1308–1315. 9 indexed citations
13.
Chen, Pao‐Yu, Jann‐Tay Wang, Sui‐Yuan Chang, et al.. (2023). Factors associated with viral rebound among COVID-19 patients receiving oral antivirals. Journal of the Formosan Medical Association. 122(8). 766–775. 5 indexed citations
14.
Sun, Hsin‐Yun, Yu‐Chung Chuang, Yu‐Shan Huang, et al.. (2023). Patient-reported outcomes among virally suppressed people living with HIV after switching to Co-formulated bictegravir, emtricitabine and tenofovir alafenamide. Journal of Microbiology Immunology and Infection. 56(3). 575–585. 13 indexed citations
15.
Liu, Wang-Da, Jann‐Tay Wang, Tai‐Ling Chao, et al.. (2022). Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19. Journal of the Formosan Medical Association. 122(8). 714–722. 3 indexed citations
16.
Cheng, Shu‐Hsing, Chia-En Lien, Szu‐Min Hsieh, et al.. (2022). A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV. Vaccines. 11(1). 18–18. 5 indexed citations
17.
18.
Sheng, Wang‐Huei, et al.. (2020). Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. Journal of the Formosan Medical Association. 120(1). 311–317. 15 indexed citations
19.
Liu, Wang-Da, Ming‐Chieh Shih, Yu‐Chung Chuang, Jann‐Tay Wang, & Wang‐Huei Sheng. (2019). Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia. Journal of Microbiology Immunology and Infection. 52(5). 788–795. 17 indexed citations
20.
Kneller, Robert, Wei‐Cheng You, Wang-Da Liu, et al.. (1992). Cigarette Smoking and Other risk Factors for progression of Precancerous Stomach Lesions. JNCI Journal of the National Cancer Institute. 84(16). 1261–1266. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeinab Mohseni Afshar Breakdown of academic impact, for papers by Wouter Haazen Breakdown of academic impact, for papers by Carolyn Brandt Breakdown of academic impact, for papers by A. Frésard Breakdown of academic impact, for papers by Serena Vita Breakdown of academic impact, for papers by Laura Barcán Breakdown of academic impact, for papers by J.‐L. Meynard Breakdown of academic impact, for papers by Rhonda E Colombo Breakdown of academic impact, for papers by R. J. A. Diepersloot
Rankless by CCL
2026